THC Tenet Healthcare Corporation New

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Rittenmeyer Ronald A	2. Issuer Name and Ticker or Trading Symbol TENET HEALTHCARE CORP [ THC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Executive Chairman and CEO
(Last)          (First)          (Middle) 1445 ROSS AVENUE, SUITE 1400	3. Date of Earliest Transaction (MM/DD/YYYY) 12/31/2019
(Street) DALLAS, TX 75202 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock (1)	12/31/2019		M		62908	A	(2)	369016	D
Common Stock	12/31/2019		F		20988 (3)	D	$38.03	348028	D
Common Stock								15000	I	By spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2019 February Restricted Stock Units	(1)	12/31/2019		M			62908	(1)	(1)	Common Stock (4)	62908	$0.00	377448	D

Explanation of Responses:
(1)	As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The third vesting date occurred on December 31, 2019, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 377,448 restricted stock units are shown in Table II.
(2)	Restricted stock units convert into common stock on a one-for-one basis.
(3)	Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
(4)	Restricted stock units are settled in shares of the Company's common stock upon vesting.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Rittenmeyer Ronald A 1445 ROSS AVENUE, SUITE 1400 DALLAS, TX 75202	X		Executive Chairman and CEO

Signatures
Mark R. Jackson, as Attorney-in-Fact for Ronald A. Rittenmeyer		1/3/2020
**Signature of Reporting Person		Date